Diabetes Dialogues

In our previous episode, we explored the scientific foundation behind treating T1D as an autoimmune disease and the critical importance of those first 100 days after diagnosis. In this episode, we shift our focus to the human side of the equation. We'll tackle the real-world hurdles families face when navigating a new T1D diagnosis - from emotional overwhelm to information overload. More importantly, we'll discuss how we can design clinical trials that work for families, not against them, and explore the transformative power of true partnerships between sponsors, CROs, and patient advocacy groups.

This episode brings together Mala Puri, Senior Medical Director at Fortrea and Dr. Sanjoy Dutta PhD Chief Scientific Officer to discuss the unique challenges faced by pediatric populations in Type 1 diabetes clinical trials. We explore the specific needs and barriers for children and their families, and the role of advocacy and research groups in supporting them. The conversation highlights practical examples of support programs and tools that can help pediatric patients participate in clinical trials, ensuring their voices are heard and their needs are met.

This episode brings together Dr. Friedrich Mittermayer and Dr. Esther Latres PhD, VP of Research, to discuss the exciting cures for T1D, and the challenges those clinical trials face. This podcast episode explores the urgent realities and untapped opportunities in adult T1D diagnosis and treatment. From the heartbreak of misdiagnosis to the promise of cell and gene therapies, we spotlight the real-world journeys that shape clinical trial access and outcomes. You’ll hear how delayed diagnoses push young adults beyond critical trial windows, why older patients are often overlooked, and how new tools—from EMR pilots to genetic rescores—are helping us find the right patients, faster. With insights from Breakthrough T1D, we rally around a shared vision: a world without T1D. Because the future of diabetes care isn’t just about innovation—it’s about inclusion.